CNS toxicity remains one of the leading causes of failure in drug development, yet it is rarely detected in preclinical studies. Among these risks, seizure liability is one of the most challenging and ...
Data highlight advancements across ElevateBio's targeted gene insertion platform, powered by retrotransposon and machine learning-optimized ...
Functional genomics is central to modern drug discovery, yet high attrition rates persist. In this article, Dr Salman ...
The main market opportunities in DLL3-targeted immunotherapies lie in the treatment of high unmet needs in small cell lung cancer and neuroendocrine carcinomas. The surge in research highlights ...
AI-driven functional precision medicine could transform cancer care by testing live tumor cells to deliver personalized, ...
A new study published in the journal of BMC Nephrology showed that dialysis selection for older individuals with end-stage ...
Pheast Therapeutics, a clinical-stage biotechnology company advancing macrophage-directed immunotherapies for cancer, today announced the identification of CDH1 (E-cadherin) as a novel ...
Savannah, Georgia - May 15, 2026 - PRESSADVANTAGE - Arrowhead Clinic Chiropractor Savannah continues to provide ...
Hosted on MSN
Making sense of physical therapy modalities
Physical therapy modalities—from ultrasound to cryotherapy—can play a key role in pain relief, recovery, and functional improvement when used in the right context. Current clinical resources highlight ...
A collage of a woman wearing red light therapy devices. I’ve reached a delightful era of my life wherein I’m regularly ...
Repetitive transcranial magnetic stimulation is already FDA approved for major depressive disorder. Researchers think it could offer drug-free relief for moms.
Contrary to prior work, principal axes of structural and functional connectivity are established early in life, remaining stable and undergoing refinement throughout development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results